Skip to menu Skip to content Skip to footer

2024

Journal Article

Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma

MacManus, Michael P., Seymour, John F., Tsang, Hennes, Fisher, Richard, Keane, Colm, Sabdia, Muhammed B., Law, Soi C., Gunawardana, Jay, Nath, Karthik, Kazakoff, Stephen H., Marques-Piubelli, Mario L., Duenas, Daniela E., Green, Michael R., Roos, Daniel, O'Brien, Peter, McCann, Andrew, Tsang, Richard, Davis, Sidney, Christie, David, Cheah, Chan, Amanuel, Benhur, Cochrane, Tara, Butler, Jason, Johnston, Anna, Shanavas, Mohamed, Li, Li, Vajdic, Claire, Kridel, Robert, Shelton, Victoria ... Tobin, Joshua W.D. (2024). Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma. eBioMedicine, 110 105468, 105468. doi: 10.1016/j.ebiom.2024.105468

Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma

2024

Journal Article

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study

Verner, Emma, Johnston, Amanda, Pati, Nalini, Hawkes, Eliza A., Lee, Hui-Peng, Cochrane, Tara, Cheah, Chan Yoon, Filshie, Robin, Purtill, Duncan, Sia, Hanlon, Enjeti, Anoop K., Brown, Christina, Murphy, Nicholas, Curnow, Jennifer, Lee, Kenneth, Gandhi, Maher K., Walia, Mannu, Butcher, Belinda E. and Trotman, Judith (2024). Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study. Blood Advances, 8 (21), 5674-5682. doi: 10.1182/bloodadvances.2024014035

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study

2024

Journal Article

Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy

Hershenfeld, Samantha A., Tobin, Josuha W. D., Shelton, Victoria, Calvente, Lourdes, Lajkosz, Katherine, Liu, Ting, Brodtkorb, Marianne, d'Amore, Francesco Annibale, Ludvigsen, Maja, Baetz, Tara, LeBrun, David, Johnson, Nathalie, Crump, Michael, Hong, Michael, Kuruvilla, John, Tremblay-LeMay, Rosemarie, MacManus, Michael, Tsang, Richard, Hodgson, David C., Gandhi, Maher K. and Kridel, Robert (2024). Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy. British Journal of Haematology, 205 (5), 1810-1814. doi: 10.1111/bjh.19698

Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy

2024

Journal Article

The Post-transplant Lymphoproliferative Disorders—Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) study methods and protocol

Dharnidharka, Vikas R., Wylie, Kristine M., Wylie, Todd N., Ruzinova, Marianna B., Goss, Charles W., Storch, Gregory A., Mehta-Shah, Neha, Byers, Derek, Walther, Leslie, Jaza, Lujain, Gu, Hongjie, Agarwal, Mansi, Green, Michael, Moore, Erika, Swerdlow, Steven H., Silveira, Fernanda, Marks, Lianna J., Gratzinger, Dita, Bagg, Adam, Law, Soi Cheng and Gandhi, Maher (2024). The Post-transplant Lymphoproliferative Disorders—Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) study methods and protocol. Transplantation Direct, 10 (11) e1723, 1-9. doi: 10.1097/txd.0000000000001723

The Post-transplant Lymphoproliferative Disorders—Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) study methods and protocol

2024

Journal Article

Systemic diffuse large B-cell lymphoma involving the central nervous system have high rates of defective antigen presentation and immune surveillance

Wight, Joel, Blombery, Piers, Lickiss, Jennifer, Burgess, Melinda, Gould, Clare, Minson, Adrian, Swain, Fiona, Sabdia, Muhammed B., Gandhi, Maher K., Birchley, Andrew, Keane, Colm and Hawkes, Eliza A. (2024). Systemic diffuse large B-cell lymphoma involving the central nervous system have high rates of defective antigen presentation and immune surveillance. Haematologica, 109 (9), 3013-3018. doi: 10.3324/haematol.2023.284600

Systemic diffuse large B-cell lymphoma involving the central nervous system have high rates of defective antigen presentation and immune surveillance

2024

Journal Article

Intra‐tumoral and peripheral blood <scp>TIGIT</scp> and <scp>PD</scp>‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma

Gunawardana, Jay, Law, Soi C., Sabdia, Muhammed B., Fennell, Éanna, Hennessy, Aoife, Leahy, Ciara I., Murray, Paul G., Bednarska, Karolina, Brosda, Sandra, Trotman, Judith, Berkahn, Leanne, Zaharia, Andreea, Birch, Simone, Burgess, Melinda, Talaulikar, Dipti, Lee, Justina N., Jude, Emily, Hawkes, Eliza A., Jain, Sanjiv, Nath, Karthik, Snell, Cameron, Swain, Fiona, Tobin, Joshua W. D., Keane, Colm, Shanavas, Mohamed, Blyth, Emily, Steidl, Christian, Savage, Kerry, Farinha, Pedro ... Gandhi, Maher K. (2024). Intra‐tumoral and peripheral blood TIGIT and PD‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma. American Journal of Hematology, 99 (11), 2096-2107. doi: 10.1002/ajh.27459

Intra‐tumoral and peripheral blood <scp>TIGIT</scp> and <scp>PD</scp>‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma

2024

Journal Article

Identification of genetic subtypes in follicular lymphoma

Shelton, Victoria, Detroja, Rajesh, Liu, Ting, Isaev, Keren, Silva, Anjali, Passerini, Verena, Bakhtiari, Mehran, Calvente, Lourdes, Hong, Michael, He, Michael Y., Modi, Saloni, Hershenfeld, Samantha A., Ludvigsen, Maja, Madsen, Charlotte, Hamilton-Dutoit, Stephen, d’Amore, Francesco Annibale, Brodtkorb, Marianne, Johnson, Nathalie A., Baetz, Tara, LeBrun, David, Tobin, Josh W. D., Gandhi, Maher K., Mungall, Andrew J., Xu, Wei, Ben-Neriah, Susana, Steidl, Christian, Delabie, Jan, Tremblay-LeMay, Rosemarie, Jegede, Opeyemi ... Kridel, Robert (2024). Identification of genetic subtypes in follicular lymphoma. Blood Cancer Journal, 14 (1) 128, 128. doi: 10.1038/s41408-024-01111-w

Identification of genetic subtypes in follicular lymphoma

2024

Journal Article

Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapy

Casey, Mika, Lee, Carol, Hoyte, Sharon M., Johnston, Rebecca L., Kwok, Wing Yu, Law, Soi Cheng, Gandhi, Maher K., Harrison, Simon J. and Nakamura, Kyohei (2024). Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapy. Haematologica, 109 (7), 2131-2143. doi: 10.3324/haematol.2023.284435

Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapy

2024

Journal Article

EBNA2: a viral maestra conducting a symphony orchestra

Gandhi, Maher K. and Kelly, Gemma L. (2024). EBNA2: a viral maestra conducting a symphony orchestra. Blood, 143 (5), 384-385. doi: 10.1182/blood.2023022744

EBNA2: a viral maestra conducting a symphony orchestra

2024

Journal Article

Epstein–Barr virus‐associated lymphomas decoded

Bednarska, Karolina, Chowdhury, Rakin, Tobin, Joshua W. D., Swain, Fiona, Keane, Colm, Boyle, Stephen, Khanna, Rajiv and Gandhi, Maher K. (2024). Epstein–Barr virus‐associated lymphomas decoded. British Journal of Haematology, 204 (2), 415-433. doi: 10.1111/bjh.19255

Epstein–Barr virus‐associated lymphomas decoded

2024

Journal Article

EBV-infected hematopoietic stem cells drive CAEBV

Khanna, Rajiv and Gandhi, Maher K. (2024). EBV-infected hematopoietic stem cells drive CAEBV. Blood, 143 (1), 2-4. doi: 10.1182/blood.2023022739

EBV-infected hematopoietic stem cells drive CAEBV

2024

Journal Article

The IRE1α endonuclease plays a dual role in regulating the XBP1/miRNA-34a axis and PD-1 Expression within natural killer cells in Hodgkin lymphoma

Bednarska, Karolina, Thillaiyampalam, Gayathri, Mujaj, Sally, Nourse, Jamie, Gunawardana, Jay, Sabdia, Muhammed B., Law, Soi C., Pilaar, Anna, Cui, Qingyan, de Long, Lilia M., Vari, Frank, Gandhi, Maher K. and Cristino, Alexandre S. (2024). The IRE1α endonuclease plays a dual role in regulating the XBP1/miRNA-34a axis and PD-1 Expression within natural killer cells in Hodgkin lymphoma. Acta Haematologica, 147 (6), 1-16. doi: 10.1159/000536044

The IRE1α endonuclease plays a dual role in regulating the XBP1/miRNA-34a axis and PD-1 Expression within natural killer cells in Hodgkin lymphoma

2023

Journal Article

Genome-wide transcription factor binding maps reveal cell-specific changes in the regulatory architecture of human HSPC

Subramanian, Shruthi, Thoms, Julie A I, Huang, Yizhou, Cornejo Paramo, Carina Paola, Koch, Forrest Charles, Jacquelin, Sebastien, Shen, Sylvie, Song, Emma, Joshi, Swapna, Brownlee, Christopher Peter, Woll, Petter S., Chacon-Fajardo, Diego, Beck, Dominik, Curtis, David J, Yehson, Kenneth, Antonenas, Vicki, O'Brien, Tracey, Trickett, Annette, Powell, Jason A., Lewis, Ian D, Pitson, Stuart M, Gandhi, Maher K., Lane, Steven W, Vafaee, Fatemeh, Wong, Emily, Gottgens, Berthold, Rokny, Hamid, Wong, Jason Wing Hon and Pimanda, John E (2023). Genome-wide transcription factor binding maps reveal cell-specific changes in the regulatory architecture of human HSPC. Blood Journal, 142 (17), 1448-1462. doi: 10.1182/blood.2023021120

Genome-wide transcription factor binding maps reveal cell-specific changes in the regulatory architecture of human HSPC

2023

Journal Article

Regulatory T cells hamper the efficacy of T-cell engaging bispecific antibody therapy

Casey, Mika, Lee, Carol, Kwok, Wing Yu, Law, Soi Cheng, Corvino, Dillon, Gandhi, Maher K., Harrison, Simon J. and Nakamura, Kyohei (2023). Regulatory T cells hamper the efficacy of T-cell engaging bispecific antibody therapy. Haematologica, 109 (3), 787-798. doi: 10.3324/haematol.2023.283758

Regulatory T cells hamper the efficacy of T-cell engaging bispecific antibody therapy

2023

Journal Article

Expanding the bacterial origins of nodular lymphocyte predominant Hodgkin lymphoma

Gandhi, Maher K. and Keane, Colm (2023). Expanding the bacterial origins of nodular lymphocyte predominant Hodgkin lymphoma. Haematologica, 108 (12), 3195-3196. doi: 10.3324/haematol.2023.283392

Expanding the bacterial origins of nodular lymphocyte predominant Hodgkin lymphoma

2023

Journal Article

Resolution of melanoma to PD-1 blockade but simultaneous rapid progression of concomitant chronic lymphocytic leukemia

Burgess, Melinda, Keane, Colm, Tobin, Joshua W. D., Law, Soi Cheng, Griffin, Alison, Gill, Devinder, Ewing, Adam D., Atkinson, Victoria, Mollee, Peter, Sabdia, Muhammed B., Saunders, Nicholas and Gandhi, Maher K. (2023). Resolution of melanoma to PD-1 blockade but simultaneous rapid progression of concomitant chronic lymphocytic leukemia. Acta Haematologica, 146 (2), 166-171. doi: 10.1159/000527631

Resolution of melanoma to PD-1 blockade but simultaneous rapid progression of concomitant chronic lymphocytic leukemia

2023

Journal Article

A coordinated strategy for a simple, pragmatic approach to the early identification of the ultra‐high‐risk patient with diffuse large B‐cell lymphoma

George, Hannah, Gunawardana, Jay, Keane, Colm, Hicks, Rod J. and Gandhi, Maher K. (2023). A coordinated strategy for a simple, pragmatic approach to the early identification of the ultra‐high‐risk patient with diffuse large B‐cell lymphoma. Internal Medicine Journal, 53 (7), 1105-1109. doi: 10.1111/imj.16078

A coordinated strategy for a simple, pragmatic approach to the early identification of the ultra‐high‐risk patient with diffuse large B‐cell lymphoma

2023

Journal Article

Genetic susceptibility to EBV-related disease

Gandhi, Maher K. (2023). Genetic susceptibility to EBV-related disease. Blood, 141 (13), 1499-1500. doi: 10.1182/blood.2022019180

Genetic susceptibility to EBV-related disease

2023

Journal Article

EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort

Agrawal, Prashasti, David, Kevin A., Chen, Zhengming, Sundaram, Suchitra, Kim, Seo-Hyun, Vaca, Ryan, Lin, Yong, Singer, Samuel, Malecek, Mary-Kate, Carter, Jordan, Zayac, Adam, Kim, Myung Sun, Reddy, Nishitha, Ney, Douglas, Habib, Alma, Strouse, Christopher, Graber, Jerome, Bachanova, Veronika, Salman, Sidra, Vendiola, Jean A., Hossain, Nasheed, Tsang, Mazie, Major, Ajay, Gandhi, Maher K., Keane, Colm, Bond, David A., Folstad, Matthew, Chang, Julie, Mier-Hicks, Angel ... Martin, Peter (2023). EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Leukemia and Lymphoma, 64 (5), 1026-1034. doi: 10.1080/10428194.2023.2191152

EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort

2023

Journal Article

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive after Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study

Trotman, Judith, Presgrave, Peter, Carradice, Duncan P., Lenton, Douglas Stuart, Gandhi, Maher K., Cochrane, Tara, Badoux, Xavier, Carlson, Julia, Nkhoma, Gloria, Butcher, Belinda, Nikpour, Armin, Fulham, Michael and Johnston, Anna M. (2023). Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive after Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study. HemaSphere, 7 (3), e836. doi: 10.1097/HS9.0000000000000836

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive after Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study